Journal Article

Characterisation of microbiota in saliva, bronchoalveolar lavage fluid, non-malignant, peritumoural and tumour tissue in non-small cell lung cancer patients: a cross-sectional clinical trial

Delmas, Eve, Filaire, Edith, Filaire, Marc, Vasson, Marie-Paule, Molnar, Ioana, Berthon, Jean-Yves, Bingula, Rea, Bernalier-Donadille, Annick

2020

Overview

Background While well-characterised on its molecular base, non-small cell lung cancer (NSCLC) and its interaction with local microbiota remains scarcely explored. Moreover, current studies vary in source of lung microbiota, from bronchoalveolar lavage fluid (BAL) to tissue, introducing potentially differing results. Therefore, the objective of this study was to provide detailed characterisation of the oral and multi-source lung microbiota of direct interest in lung cancer research. Since lung tumours in lower lobes (LL) have been associated with decreased survival, characteristics of the microbiota in upper (UL) and lower tumour lobes have also been examined. Methods Using 16S rRNA gene sequencing technology, we analysed microbiota in saliva, BAL (obtained directly on excised lobe), non-malignant, peritumoural and tumour tissue from 18 NSCLC patients eligible for surgical treatment. Detailed taxonomy, diversity and core members were provided for each microbiota, with analysis of differential abundance on all taxonomical levels (zero-inflated binomial general linear model with Benjamini-Hochberg correction), between samples and lobe locations. Results Diversity and differential abundance analysis showed clear separation of oral and lung microbiota, but more importantly, of BAL and lung tissue microbiota. Phylum Proteobacteria dominated tissue samples, while Firmicutes was more abundant in BAL and saliva (with class Clostridia and Bacilli , respectively). However, all samples showed increased abundance of phylum Firmicutes in LL, with decrease in Proteobacteria . Also, clades Actinobacteria and Flavobacteriia showed inverse abundance between BAL and extratumoural tissues depending on the lobe location. While tumour microbiota seemed the least affected by location, peritumoural tissue showed the highest susceptibility with markedly increased similarity to BAL microbiota in UL. Differences between the three lung tissues were however very limited. Conclusions Our results confirm that BAL harbours unique lung microbiota and emphasise the importance of the sample choice for lung microbiota analysis. Further, limited differences between the tissues indicate that different local tumour-related factors, such as tumour type, stage or associated immunity, might be the ones responsible for microbiota-shaping effect. Finally, the “shift” towards Firmicutes in LL might be a sign of increased pathogenicity, as suggested in similar malignancies, and connected to worse prognosis of the LL tumours. Trial registration ClinicalTrials.gov ID: NCT03068663 . Registered February 27, 2017.

• Publisher: BioMed Central,BioMed Central Ltd,Nature Publishing Group,BMC
• Subject: Aged / Alveoli / Bacilli / Bronchoalveolar Lavage / Bronchoalveolar Lavage Fluid - microbiology / Bronchus / Cancer patients / Cancer therapies / Carcinoma, Non-Small-Cell Lung - genetics / Carcinoma, Non-Small-Cell Lung - metabolism / Carcinoma, Non-Small-Cell Lung - microbiology / Chemotherapy / Chronic obstructive pulmonary disease / Cross-Sectional Studies / Deoxyribonucleic acid / DNA / Female / Firmicutes / Gene sequencing / Health aspects / Humans / Lavage / Life Sciences / Lobes / Lung cancer / Lung microbiota / Lung Neoplasms - genetics / Lung Neoplasms - metabolism / Lung Neoplasms - microbiology / Male / Medicine / Medicine & Public Health / Microbiology and Parasitology / Microbiota / Microbiota (Symbiotic organisms) / Microbiota - physiology / Microorganisms / Middle Aged / Non-malignant lung tissue / Non-small cell lung cancer / Non-small cell lung carcinoma / Pathogenicity / Pathogens / Patients / Peritumoural lung tissue / Physiological aspects / Physiology / Pneumology/Respiratory System / Prospective Studies / Proteobacteria / rRNA 16S / Saliva / Saliva - metabolism / Saliva - microbiology / Small cell lung carcinoma / Studies / Surgery / Taxonomy / Technology assessment / Tissues / Tumors